Stay updated on Lorlatinib in ROS1+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.

Latest updates to the Lorlatinib in ROS1+ NSCLC Clinical Trial page
- Check7 days agoChange DetectedThe history now shows Revision: v3.7.0 as the latest entry, while Revision: v3.6.6 is removed. This reflects an update to the record's revision history.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedA new latest revision, v3.6.6, is added to the study's Record History. The previous revision, v3.6.5, is removed from the current list, reflecting an update to the record.SummaryDifference0.1%

- Check50 days agoChange DetectedA new revision entry v3.6.5 was added to the record history and the prior v3.6.4 entry was removed, indicating an update to the study's version history.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision (v3.6.4) has been added to the Study Record History, replacing the previous revision (v3.6.3). This reflects an updated version of the record.SummaryDifference0.1%

- Check85 days agoChange DetectedThe study record history now shows a new revision entry labeled v3.6.3, indicating the record has been updated to a newer saved version.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision history now shows a new entry for v3.6.2 and removes the v3.6.0 entry, updating the page's version log. This reflects internal version control for the page and does not alter the study data or status.SummaryDifference0.1%

Stay in the know with updates to Lorlatinib in ROS1+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.